Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety

Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety

Abstract Background The optimal strategy for adjuvant therapy after curative resection for hepatocellular carcinoma (HCC) patients with solitary tumor and microvascular invasion (MVI) is controversial. This trial evaluated the efficacy and safety of adjuvant transcatheter arterial chemoembolization...

Full description

Bibliographic Details
Main Authors: Wei Wei, Pei-En Jian, Shao-Hua Li, Zhi-Xing Guo, Yong-Fa Zhang, Yi-Hong Ling, Xiao-Jun Lin, Li Xu, Ming Shi, Lie Zheng, Min-Shan Chen, Rong-Ping Guo
Format: Article
Language:English
Published: Wiley 2018-10-01
Series:Cancer Communications
Subjects:
Solitary tumor
Hepatocellular carcinoma
Adjuvant therapy
Transcatheter arterial chemoembolization
Hepatectomy alone
Microvascular invasion
Online Access:http://link.springer.com/article/10.1186/s40880-018-0331-y

Internet

http://link.springer.com/article/10.1186/s40880-018-0331-y

Similar Items